Would it be preferable for the institution to be private or public? That was really my question. This is what Genome Canada, Biotech and a few others are trying to do. These people work with pharmaceutical companies. At the end of the day, there is not enough money, not enough venture capital and these people are not really ready. In Quebec, the Fonds de solidarité does invest somewhat, but not in a speculative way. This sector is experiencing a crisis.
On March 5th, 2008. See this statement in context.